Larvol Delta - A-Phase-3-Study-of-Sosimerasib-in-Combination-With-IN10018-Versus-Standard-Therapy-for-First-Line-Nonsquamous-Nonsmall-Cell-Lung-Cancer-With-KRAS-G12C-Mutation

pemetrexed - Generic mfg.

ifebemtinib (IN10018) - InxMed

carboplatin - Generic mfg.

sosimerasib (HBI-2438) - HUYA Bioscience

Tevimbra (tislelizumab-jsgr) - BeOne Medicines

http://clinicaltrials.gov/ct2/show/NCT07833202

Sep 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next